HEERLEN, THE NETHERLANDS--(Marketwired - Apr 8, 2013) - Royal DSM, the global Life Sciences
and Materials Sciences company, announces
today that it has completed the acquisition of Tortuga Companhia
Zootécnica
Agrária (Tortuga), a nutritional supplements company with a focus on
pasture
raised beef and dairy cattle for a total enterprise value of about EUR440
million
(BRL 1,160 million). The acquisition was announced on 8 August 2012.
Tortuga, the Brazilian market leader in organic trace minerals for animal
nutrition and health with a focus on pasture raised beef and dairy cattle,
strengthens DSM's position in nutritional supplements and additives for
ruminants and our presence in Brazil, one of the leading ruminant markets
in the
world.
Tortuga also broadens DSM's animal nutrition ingredients portfolio with the
highly attractive organic trace minerals, while offering many value
creating
synergies. Tortuga is headquartered in Sao Paulo, Brazil with approximately
1,200 employees.
Stephan Tanda, Member of the DSM Managing Board and responsible for the
Nutrition cluster, commented: "Completing the acquisition of Tortuga is a
major
step in the implementation of DSM's Nutrition strategy. Our attention is
now
fully focused on ensuring a smooth integration of the Tortuga business in a
timely and efficient manner, with business continuity and customer
satisfaction
as key priorities for us while we welcome Tortuga's 1,200 employees to
DSM."
Full scale integration will now begin. A dedicated integration team
consisting
of both DSM and Tortuga representatives will work diligently to assess the
best
way to execute the integration while focusing on future synergy generation.
DSM - Bright Science. Brighter Living.™
Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and
Materials
Sciences DSM is driving economic prosperity, environmental progress and
social
advances to create sustainable value for all stakeholders. DSM delivers
innovative solutions that nourish, protect and improve performance in
global
markets such as food and dietary supplements, personal care, feed,
pharmaceuticals, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials.
DSM's
23,500 employees deliver annual net sales of around EUR9 billion. The
company is
listed on NYSE Euronext.
More information can be found at www.dsm.com.
Press release-pdf:
http://hugin.info/130663/R/1690588/555022.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: DSM N.V. via Thomson Reuters ONE
[HUG#1690588]
For more information:
DSM Corporate Communications
Herman Betten
tel. +31 (0) 45 5782017
e-mail Email Contact
DSM Investor Relations
Dave Huizing
tel. +31 (0) 45 5782864
fax +31 (0) 10 4590275
e-mail Email Contact
View More
View More
